Cervical squamous cell carcinoma (CESC), the most prevalent subtype of cervical cancer, remains a major global health burden ...

AI can be used to detect cervical cancer in women in resource-limited parts of the world. However, for this method to work, investments are needed in health care staff, reliable supply chains and ...

Each year, more than 340,000 women die from cervical cancer, with the majority of deaths occurring in low- and middle-income countries. Despite being highly preventable through vaccination and early ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Erin Andrews is no stranger to the spotlight. And as a NFL broadcaster, she's used to being one of the few women in the room in a male-dominated industry. This is one of the reasons she said she felt ...

Brown University Health is offering free breast and cervical screenings Saturday, Oct. 25, from 8:30 a.m. to 3 p.m. This is part of breast cancer awareness month. There are 50 appointments available ...

NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer screening, has teamed up with Laurel Bridge Software, a leader in ...

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...

Scientists at Mass General Brigham have created HPV-DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, ...

In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sample types. From ...

While the benefits of screening tests for cervical cancer, breast cancer, and colorectal cancer are widely accepted, screening for prostate cancer remains controversial to some. The main screening ...